NJ Center for Tourette Syndrome Webinar Series: "Medication Management" and "TS in the Latino Community"
Review the May 8 webinar on "Medication Management for Tics and TS" and preview the June 19 webinar on "TS in the Latino Community."
Somerville, NJ, May 15, 2013 --(PR.com)-- Dr. Mark Mintz, Psy.D, discussed “Managing Medication for Tics and Tourette Syndrome” during the New Jersey Center for Tourette Syndrome & Associated Disorders (NJCTS) Wednesday Webinar on May 8.
This webinar – which was aimed at professionals, therapists, and persons and their families dealing with Tourette and associated disorders such as OCD, ADHD, anxiety, depression and mood disorders – explained the biological rationale for using medications for tics and TS, the various types of drugs that have shown to be beneficial, and discuss the risks and benefits of medication therapies. Here is some feedback NJCTS received on the webinar:
"Your topics are timely and a saving grace. They fit into my daily schedule. Just to note, one of my teenagers sat down to watch the end with me!” – Adriana from New Jersey
“The information about generics not necessarily functioning the same as brand name drugs was very interesting and helpful. I will be sure to check my son's Rx more carefully.” – Laura from New Jersey
“I learned that: 1) There may be a difference between generic drugs and name-brand drugs, and that some companies that produce brand name drugs, also produce generic drugs; 2) even people without ADHD may respond to stimulant medication so positive response to the medication may not prove that one has the condition; 3) it is possible for a person to develop tics from ADHD medication; and 4) by researching ones genes, it will be possible to see whether a certain medication will work or might harm a person.” – Naomi from New Jersey
NJCTS' next webinar -- "TS in the Latino Community" -- will take place on June 19. Dr. Richard Zakreski, Psy.D, will discuss how Tourette Syndrome -- which affects all ethnic groups -- has in particular impacted the Hispanic community in urban areas of New Jersey, the nation and the world. Registration and more information for this webinar will be available soon at http://www.njcts.org.
The Wednesday Webinar series, which draws an audience from 48 states and 13 countries, was launched in 2008. The series, offered at no cost to participants, features online seminars for parents, educators and professionals on topics of interest to the TS and associated disorders community. Professional development credits are given upon verification of attendance and completion of an exit survey. Credits are distributed by mail one week after the webinar.
This webinar – which was aimed at professionals, therapists, and persons and their families dealing with Tourette and associated disorders such as OCD, ADHD, anxiety, depression and mood disorders – explained the biological rationale for using medications for tics and TS, the various types of drugs that have shown to be beneficial, and discuss the risks and benefits of medication therapies. Here is some feedback NJCTS received on the webinar:
"Your topics are timely and a saving grace. They fit into my daily schedule. Just to note, one of my teenagers sat down to watch the end with me!” – Adriana from New Jersey
“The information about generics not necessarily functioning the same as brand name drugs was very interesting and helpful. I will be sure to check my son's Rx more carefully.” – Laura from New Jersey
“I learned that: 1) There may be a difference between generic drugs and name-brand drugs, and that some companies that produce brand name drugs, also produce generic drugs; 2) even people without ADHD may respond to stimulant medication so positive response to the medication may not prove that one has the condition; 3) it is possible for a person to develop tics from ADHD medication; and 4) by researching ones genes, it will be possible to see whether a certain medication will work or might harm a person.” – Naomi from New Jersey
NJCTS' next webinar -- "TS in the Latino Community" -- will take place on June 19. Dr. Richard Zakreski, Psy.D, will discuss how Tourette Syndrome -- which affects all ethnic groups -- has in particular impacted the Hispanic community in urban areas of New Jersey, the nation and the world. Registration and more information for this webinar will be available soon at http://www.njcts.org.
The Wednesday Webinar series, which draws an audience from 48 states and 13 countries, was launched in 2008. The series, offered at no cost to participants, features online seminars for parents, educators and professionals on topics of interest to the TS and associated disorders community. Professional development credits are given upon verification of attendance and completion of an exit survey. Credits are distributed by mail one week after the webinar.
Contact
New Jersey Center for Tourette Syndrome
Jeff Weber
908-575-7350
www.njcts.org
Jeff Weber
908-575-7350
www.njcts.org
Contact
Categories